Explain this page
Arphra AIPlain-English read on Bristol-Myers Squibb Company’s valuationReports tracked
24
Beat rate
0%
0 beats · 12 misses (last 12)
Next report
Jul 30, 2026
Est. EPS $1.64
Last report
Apr 30, 2026
Surprise history (last 16 quarters)
No surprise data available.
Upcoming reports
| Date | EPS estimate | Revenue estimate |
|---|---|---|
| Jul 30, 2026 | $1.64 | $11.75B |
| Oct 29, 2026 | $1.61 | $12.04B |
Earnings history
| Date | EPS · est | EPS · actual | Surprise | Revenue · est | Revenue · actual | Result |
|---|---|---|---|---|---|---|
| Apr 30, 2026 | $1.42 | — | — | $10.93B | — | — |
| Feb 05, 2026 | $1.23 | — | — | $12.28B | — | — |
| Oct 30, 2025 | $1.52 | — | — | $11.85B | — | — |
| Jul 31, 2025 | $1.09 | — | — | $11.44B | — | — |
| Apr 24, 2025 | $1.49 | — | — | $10.7B | — | — |
| Feb 06, 2025 | $1.47 | — | — | $11.57B | — | — |
| Oct 31, 2024 | $1.49 | — | — | $11.26B | — | — |
| Jul 26, 2024 | $1.62 | — | — | $11.54B | — | — |
| Apr 25, 2024 | $-4.41 | — | — | $11.48B | — | — |
| Feb 02, 2024 | $1.52 | — | — | $11.19B | — | — |
| Oct 26, 2023 | $1.76 | — | — | $10.97B | — | — |
| Jul 27, 2023 | $1.99 | — | — | $11.8B | — | — |
| Apr 27, 2023 | $1.98 | — | — | $11.49B | — | — |
| Feb 02, 2023 | $1.71 | — | — | $11.19B | — | — |
| Oct 25, 2022 | $1.83 | — | — | $11.14B | — | — |
| Jul 27, 2022 | $1.79 | — | — | $11.42B | — | — |
Analyst estimates · annual
| Period | EPS · avg | Revenue · avg | # Analysts |
|---|---|---|---|
| No analyst estimates returned. | |||
Analyst estimates · quarterly
| Period | EPS · avg | Revenue · avg | # Analysts |
|---|---|---|---|
| No analyst estimates returned. | |||